Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Turning Point Therapeutics
Turning Point Therapeutics
BMS gets US approval for ROS1 lung cancer drug Augtyro
Pharmaphorum
Thu, 11/16/23 - 10:11 am
Bristol Myers Squibb
Augtyro
Turning Point Therapeutics
lung cancer
FDA
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx
Bristol Myers completes Turning Point Acquisition
Pharmaceutical Business Review
Thu, 08/18/22 - 10:50 am
Bristol Myers Squibb
M&A
Turning Point Therapeutics
oncogenesis
Biopharma takeout spend ticks up
EP Vantage
Tue, 07/5/22 - 11:02 am
M&A
biotech
Pfizer
Biohaven
Bristol Myers Squibb
Turning Point Therapeutics
GSK
Affinivax
Sierra Oncology
Halozyme Therapeutics
Antares Pharma
Bristol Myers bets $4B on Turning Point and its targeted cancer drugs
BioPharma Dive
Fri, 06/3/22 - 10:56 am
Bristol Myers Squibb
M&A
Turning Point Therapeutics
Turning Point looks to challenge Pfizer, Roche with new early data for lead lung cancer drug
Endpoints
Wed, 04/13/22 - 05:37 pm
Turning Point Therapeutics
Pfizer
Roche
repotrectinib
clinical trials
non-small cell lung cancer
Triple meeting – the point of turning to TPX-0022
EP Vantage
Tue, 10/27/20 - 10:32 am
Turning Point Therapeutics
repotrectinib
TPX-0022
non-small cell lung cancer
Turning Point touts positive pivotal NSCLC data, hints at even faster OK — but can it beat Pfizer and Roche?
Endpoints
Wed, 08/19/20 - 12:18 pm
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
clinical trials
Pfizer
Roche
Important catalysts approach for smaller biotechs
EP Vantage
Wed, 06/24/20 - 10:35 am
BeiGene
Turning Point Therapeutics
Intra-Cellular Therapies
Immunovant
Caplyta
Brukinsa
repotrectinib
IMVT-1401
clinical trials
Biotech companies raise cash as coronavirus updates lift stocks
BioPharma Dive
Tue, 05/19/20 - 11:24 pm
biotech
biotech stocks
COVID-19
Moderna Therapeutics
Bluebird Bio
Turning Point Therapeutics
Gossamer Bio
Krystal Biotech
Clovis Oncology
Gamida Cell
Bellerophon
Turning Point Therapeutics Files for $296 Million Offering
CP Wire
Tue, 09/3/19 - 04:43 pm
Turning Point Therapeutics
Turning Point Therapeutics Files for $296 Million Offering
Tue, 09/3/19 - 04:36 pm
Turning Point Therapeutics
Back to business for biotech flotations
EP Vantage
Wed, 07/3/19 - 09:48 am
IPOs
BridgeBio
Turning Point Therapeutics
Stoke Therapeutics
Prevail Therapeutics
Atreca
NGM Biopharmaceuticals
Akero Therapeutics
Milestone Pharmaceuticals
Morphic Therapeutics
Karuna
3 takeaways from cancer's biggest conference
Biopharma Dive
Thu, 06/6/19 - 10:03 pm
Amgen
KRAS
accelerated approvals
Turning Point Therapeutics
Keytruda
Opdivo
ASCO 2019
ASCO: Death in Turning Point NSCLC trial overshadows 82% ORR
Fierce Biotech
Mon, 06/3/19 - 11:43 am
ASCO 2019
clinical trials
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
Turning Point sinks on ASCO update for repotrectinib
BioCentury
Fri, 05/31/19 - 11:59 pm
ASCO 2019
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Sun, 04/14/19 - 03:57 pm
Wave Life Sciences
Sarepta Therapeutics
Novavax
ContraFect
Scynexis
earnings
Abbott Labs
Intuitive Surgical
Brainsway
Hookipa
Turning Point Therapeutics
IPOs
Turning Point Therapeutics Updates Its IPO Filing – Will Raise Up to $152 Million
CP Wire
Mon, 04/8/19 - 09:42 am
IPOs
Turning Point Therapeutics
Turning Point Therapeutics Updates Its IPO Filing – Will Raise Up to $152 Million
Mon, 04/8/19 - 09:40 am
Turning Point Therapeutics
IPOs
Early Stage Oncology Biotech Files for $100 Million IPO
CP Wire
Fri, 03/22/19 - 09:59 am
Turning Point Therapeutics
IPOs
oncology
Pages
1
2
next ›
last »